Nanotechnology-Based Drug Delivery Systems for Treatment of Hyperproliferative Skin Diseases - A Review

Publisher: Bentham Science Publishers

E-ISSN: 1875-6786|9|1|159-167

ISSN: 1573-4137

Source: Current Nanoscience, Vol.9, Iss.1, 2013-01, pp. : 159-167

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

The chronic hyperproliferative diseases (CHD) include cancer, precancerous lesions and diseases of unknown etiology such aspsoriasis. Various drugs have been used in the treatment of CHD, such as antiproliferative and corticosteroids in general. However, somedrugs have properties that limit their effectiveness, such as low solubility in water and low penetration of the skin. Thus, the control ofdrug release in the skin may improve efficacy and reduce side effects of many drugs used in hyperproliferative diseases. The purpose ofthis study was to make a systematic review of nanotechnology-based drug delivery systems used against hyperproliferative skin diseases.